Ankeny, Iowa (June 6, 2005) – Proliant Health Ingredients announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
ImmunoLin is a natural, casein-free,lactose-free, soluble, protein isolate with a clean taste and light color.
The Clinical Trial “The Efficacy of Bovine Serum Globulin (BSG) on Symptoms, General Health and Quality of Life in Individuals with Diarrhea-Predominant Irritable Bowel Syndrome (IBS)” includes
45 patients with diarrhea-predominant IBS. The patients were supplemented with bovine serum globulin for 6 weeks. The primary outcome measure was the frequency and severity of loose stool. Secondary outcomes included other GI symptoms as indicated by symptom score sheet, general health as indicated by basic blood chemistry pre and post supplementation, and quality of life as indicated by the IBS-36 quality of life questionnaire.
This study is being conducted by KGK Synergize Inc. in London, Ontario with Dr. David Crowley (M.D.) as Principle Investigator. The expected completion of the study is June 17, 2005 with analysis and reporting targeted for July 1, 2005.
Proliant Health Ingredients is owned by Lauridsen Group, Inc. (LGI, Inc.) and is a leading innovator in applied protein science. Proliant Health Ingredients serves the human health and nutrition industry, including the dietary supplement, clinical nutrition, consumer health and functional food markets. For more information about Proliant Health Ingredients, visit www.proliantinc.com or call 800-369-2672.
Stauber Performance Ingredients, Inc. is our exclusive distributor in the U.S. of ingredients to dietary supplement and food manufacturers. For more information please call Stauber Performance Ingredients at 714-441-3900.
Contact: Lori Stevenson
Vice-President – Sales
Proliant Health Ingredients
Contact: Kristen Reynolds
KGK Synergize Inc.
Suite 1030, 255 Queens Ave.
London, ON N6A 5R8 Canada
519-438-9374 Ext. 222